GRCL
Gracell Biotechnologies Inc.
NASDAQ: GRCL · HEALTHCARE · BIOTECHNOLOGY
$10.25
+0.00% today
Updated 2026-04-30
Market cap
$989.87M
P/E ratio
—
P/S ratio
732.21x
EPS (TTM)
$-0.97
Dividend yield
—
52W range
$307 – $525
Volume
6.4M
Gracell Biotechnologies Inc. (GRCL) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
4 of 8
Last 8 quarters
Avg EPS surprise
+2.2%
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
+71.4%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+2.5%
Last 1 reports
Positive reaction rate
100%
1 of 1 quarters
Largest single-day move
+2.5%
2023-11-13
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2023-11-13 | $-0.10 | +50.0% | $4.40 | $4.51 | +2.5% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2023-09-30 | $-0.20 | $-0.10 | +50.0% | — | — |
| 2023-06-30 | $-0.40 | $-0.30 | +25.0% | — | — |
| 2023-03-31 | $-0.39 | $-0.35 | +10.3% | — | — |
| 2022-12-31 | $-0.17 | $-0.30 | -76.5% | — | — |
| 2022-09-30 | $-0.13 | $-0.35 | -169.2% | — | — |
| 2022-06-30 | $-0.07 | $-0.30 | -328.6% | — | — |
| 2022-03-31 | $-0.21 | $-0.35 | -66.7% | — | — |
| 2021-12-31 | $-0.33 | $-0.30 | +9.1% | — | — |
| 2021-09-30 | $-0.12 | $-0.30 | -150.0% | $366000.00 | — |
| 2021-06-30 | $-0.12 | $-0.20 | -66.7% | — | — |
| 2021-03-31 | $-0.21 | $-0.25 | -19.0% | — | — |
| 2020-12-31 | $-0.26 | $-0.16 | +38.5% | — | — |
Frequently asked questions
Has Gracell Biotechnologies Inc. beaten earnings estimates?
Gracell Biotechnologies Inc. has beaten Wall Street EPS estimates in 4 of its last 8 quarterly reports, with an average EPS surprise of +2.2% over the last 4 quarters.
How does GRCL stock react to earnings?
GRCL stock has moved an average of +2.5% in the trading day following earnings over its last 1 reports, with positive reactions in 100% of those quarters.